Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
167.64
+5.56 (3.43%)
Nov 21, 2025, 4:00 PM EST - Market closed

CRL Revenue

Charles River Laboratories International had revenue of $1.00B in the quarter ending September 27, 2025, a decrease of -0.49%. This brings the company's revenue in the last twelve months to $4.02B, down -0.92% year-over-year. In the year 2024, Charles River Laboratories International had annual revenue of $4.05B, down -1.92%.

Revenue (ttm)
$4.02B
Revenue Growth
-0.92%
P/S Ratio
2.09
Revenue / Employee
$200,184
Employees
20,100
Market Cap
8.25B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 28, 20244.05B-79.42M-1.92%
Dec 30, 20234.13B153.35M3.86%
Dec 31, 20223.98B435.90M12.31%
Dec 25, 20213.54B616.23M21.08%
Dec 26, 20202.92B302.71M11.55%
Dec 28, 20192.62B355.13M15.67%
Dec 29, 20182.27B408.50M21.99%
Dec 30, 20171.86B176.17M10.48%
Dec 31, 20161.68B318.13M23.34%
Dec 26, 20151.36B65.64M5.06%
Dec 27, 20141.30B132.13M11.34%
Dec 28, 20131.17B36.00M3.19%
Dec 29, 20121.13B-13.12M-1.15%
Dec 31, 20111.14B9.23M0.81%
Dec 25, 20101.13B-38.23M-3.26%
Dec 26, 20091.17B-123.66M-9.55%
Dec 27, 20081.30B64.67M5.26%
Dec 29, 20071.23B172.24M16.27%
Dec 30, 20061.06B65.06M6.55%
Dec 31, 2005993.33M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings